Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.78%
SPX
+0.70%
IXIC
+0.52%
FTSE
-0.56%
N225
-0.68%
AXJO
-0.58%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

About

What does NNVC do?
NanoViricides, based in Shelton, Connecticut, develops nanomedicine drugs targeting enveloped viruses, with lead candidates NV-CoV-2 for COVID-19 and NV-HHV-1 for Shingles. The company went public on August 12, 2004.
Sector
💻 Health Care
IPO
August 12, 2024
CEO
Dr. Anil R. Diwan
Employees
7
Headquarters
Connecticut, USA
Website
http://www.nanoviricides.com

Key Stats

Market Cap
22.05M
Dividend Yield
0.00%
P/E Ratio
-2.27
EPS
-0.72
Revenue
-
Avg. Volume
72.67K

Recently from Cashu

publisher logo
Cashu

Why NanoViricides (NNVC) Could Be a $6 Stock — And Why Investors Are Starting to Notice

5 days ago
publisher logo
Cashu

The Tiny Biotech Aiming to Disrupt the $80 Billion Antiviral Market: Why NanoViricides (NNVC) Deserves a Closer Look

13 days ago
publisher logo
Cashu

Could This Tiny Biotech Be the Key to Stopping a Measles Comeback?

18 days ago
Stocks
Health Care
nnvc
NanoViricides
NNVC
+0.10 (+7.63%)
1.41
USD
At close at May 16, 20:37 UTC
Summary
News
Videos
Signals
Benchmarks
Financials